The lower serum CXCL13 level of the HTLV‐1‐seropositive SS patients compared to that of the HTLV‐1‐seronegative SS patients might indicate differences in focal inflammation in salivary glands in both groups. This evidence concerns the gene CXCL13 and synovial sarcoma.